A decreasing endogenous MDM2 level (using specific siRNA) in different breast cancer cell lines led to the same conclusions: only in the case of SKBR3 cells (which represent the HER2 subtype of breast cancer) did downregulation of MDM2 gene result in the decrease in cell survival. The gene discussed is ERBB2; the disease is breast carcinoma.